T1	Drug 21 33	enzalutamide
T2	Drug 37 56	abiraterone acetate
T3	Multiplier 57 70	for > 14 days
T4	Temporal 71 90	prior to enrollment
T5	Reference_point 80 90	enrollment
R1	Has_index Arg1:T4 Arg2:T5	
*	OR T1 T2
T6	Procedure 6 15	treatment
T7	Scope 21 56	enzalutamide or abiraterone acetate
R2	Has_scope Arg1:T6 Arg2:T7	
R3	Has_multiplier Arg1:T6 Arg2:T3	
R4	Has_temporal Arg1:T6 Arg2:T4	
T8	Procedure 137 149	chemotherapy
T9	Condition 154 162;172 178	prostate cancer
T10	Qualifier 166 171	other
T11	Condition 172 178	cancer
R5	Has_qualifier Arg1:T11 Arg2:T10	
*	OR T9 T11
T12	Scope 154 178	prostate or other cancer
R6	Has_scope Arg1:T8 Arg2:T12	
T13	Temporal 179 204	within the past 12 months
R7	Has_temporal Arg1:T8 Arg2:T13	
T14	Condition 210 237	residual cognitive deficits
R8	AND Arg1:T8 Arg2:T14	
T15	Procedure 253 265	chemotherapy
T16	Condition 270 275	mCRPC
R9	AND Arg1:T15 Arg2:T16	
*	OR T8 T15
T17	Non-representable 277 402	Patients/physicians planning treatment with chemotherapy during the 12 month period of the investigation are also ineligible.
T18	Condition 415 435	cognitive impairment
T19	Condition 415 424;439 450	cognitive dysfunction
T20	Condition 475 483	dementia
T21	Condition 485 504	Alzheimer's disease
T22	Condition 506 512	stroke
T23	Condition 518 545	residual cognitive deficits
T24	Condition 547 568	cognitive dysfunction
T25	Condition 591 606	substance abuse
T26	Condition 580 587;601 606	alcohol abuse
R10	AND Arg1:T22 Arg2:T23	
*	OR T22 T24 T21 T20 T25 T26 T28
*	OR T19 T18
T27	Scope 415 450	cognitive impairment or dysfunction
T28	Condition 611 632	cognitive dysfunction
T29	Procedure 650 659	treatment
T30	Temporal 644 649	prior
T31	Condition 668 674	cancer
T32	Qualifier 664 667	any
R11	Has_qualifier Arg1:T31 Arg2:T32	
R12	AND Arg1:T29 Arg2:T31	
R13	Has_temporal Arg1:T29 Arg2:T30	
R14	AND Arg1:T28 Arg2:T29	
T33	Scope 475 674	dementia, Alzheimer's disease, stroke with residual cognitive deficits, cognitive dysfunction related to alcohol or substance abuse, or cognitive dysfunction related to prior treatment for any cancer
R15	Subsumes Arg1:T27 Arg2:T33	
T34	Condition 693 700	seizure
T35	Condition 721 736	recurrent falls
T36	Condition 747 763	brain metastases
*	OR T35 T36 T34
T37	Observation 701 708	history
T38	Observation 710 720	history of
R16	Has_temporal Arg1:T35 Arg2:T38	
R17	Has_temporal Arg1:T34 Arg2:T37	
T39	Condition 987 1007	intercurrent illness
T40	Qualifier 974 986	Uncontrolled
R18	Has_qualifier Arg1:T39 Arg2:T40	
T41	Qualifier 1039 1051	uncontrolled
T42	Condition 1052 1060	diabetes
R19	Has_qualifier Arg1:T42 Arg2:T41	
T43	Temporal 1062 1069	ongoing
T44	Qualifier 1073 1079	active
*	OR T43 T44
T45	Condition 1080 1089	infection
T46	Scope 1062 1079	ongoing or active
R20	Has_scope Arg1:T45 Arg2:T46	
T47	Qualifier 1091 1102	symptomatic
T48	Condition 1103 1127	congestive heart failure
T49	Measurement 1129 1155	New York Heart Association
T50	Value 1156 1172	Class III and IV
T51	Condition 1173 1186	heart failure
R21	AND Arg1:T51 Arg2:T49	
R22	Has_value Arg1:T49 Arg2:T50	
R23	Has_qualifier Arg1:T48 Arg2:T47	
T52	Scope 1129 1186	New York Heart Association Class III and IV heart failure
T53	Scope 1091 1127	symptomatic congestive heart failure
R24	Subsumes Arg1:T53 Arg2:T52	
T54	Condition 1189 1213	unstable angina pectoris
T55	Condition 1215 1233	cardiac arrhythmia
T56	Condition 1238 1257	psychiatric illness
T57	Condition 1258 1275	social situations
T58	Condition 1276 1291	substance abuse
*	OR T45 T42 T53 T55 T54 T57 T58 T56
T59	Scope 1039 1291	uncontrolled diabetes, ongoing or active infection, symptomatic congestive heart failure (New York Heart Association Class III and IV heart failure), unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations/substance abuse
T60	Scope 974 1007	Uncontrolled intercurrent illness
R25	Subsumes Arg1:T60 Arg2:T59	
T61	Multiplier 1381 1387	second
T62	Condition 1388 1398	malignancy
T63	Qualifier 1363 1379	currently active
T64	Condition 1410 1435	non-melanoma skin cancers
R26	Has_multiplier Arg1:T62 Arg2:T61	
T65	Negation 1399 1409	other than
R27	Has_negation Arg1:T64 Arg2:T65	
R28	AND Arg1:T62 Arg2:T64	
R29	Has_qualifier Arg1:T62 Arg2:T63	
T66	Condition 1634 1655	cognitive dysfunction
T67	Procedure 1667 1676	treatment
T68	Qualifier 1680 1687	another
T69	Condition 1688 1698	malignancy
R30	Has_qualifier Arg1:T69 Arg2:T68	
R31	AND Arg1:T67 Arg2:T69	
R32	AND Arg1:T66 Arg2:T67	
*	OR T62 T66
T70	Drug 1771 1795	psychotropic medications
T71	Drug 1799 1812	illicit drugs
T72	Condition 1822 1837	alter cognition
T73	Condition 1822 1827;1839 1852	alter concentration
T74	Condition 1822 1827;1857 1865	alter behavior
*	OR T73 T74 T72
*	OR T71 T70
T75	Scope 1771 1812	psychotropic medications or illicit drugs
T76	Scope 1822 1865	alter cognition, concentration, or behavior
R33	Has_scope Arg1:T75 Arg2:T76	
T77	Non-representable 1867 2062	Appropriate treatment by a licensed provider with medications for depression or anxiety, including but not limited to SSRIs, SNRIs, and standard dose benzodiazepines at a stable dose, is permitte
